Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033

Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6799

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Systemic Lupus Erythematosus (SLE) Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Antimalarials Drugs
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Chloroquine
           6.1.2.2 Hydroxychloroquine
        6.1.3 Market Forecast
    6.2    Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Cytotoxic and Immunosuppressive Drugs
        6.3.1 Market Trends
        6.3.2 Key Segments
           6.3.2.1 Cyclophosphamide
           6.3.2.2 Methotrexate
           6.3.2.3 Mycophenolate Mofetil
           6.3.2.4 Tacrolimus
           6.3.2.5 Cyclosporine
        6.3.3 Market Forecast
    6.4    Biologics
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Mode of Delivery
    7.1    Intravenous
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Subcutaneous
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Oral
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    Drivers, Restraints, and Opportunities
    9.1    Overview
    9.2    Drivers
    9.3    Restraints
    9.4    Opportunities
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    AstraZeneca Plc
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Aurinia Pharmaceuticals Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
        13.3.3    GSK plc
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    ImmuPharma Plc
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

​Figure 1: Global: Systemic Lupus Erythematosus Drugs Market: Major Drivers and Challenges
Figure 2: Global: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Mode of Delivery (in %), 2024
Figure 6: Global: Systemic Lupus Erythematosus Drugs Market: Breakup by Region (in %), 2024
Figure 7: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Systemic Lupus Erythematosus Drugs (Antimalarials Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Systemic Lupus Erythematosus Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Systemic Lupus Erythematosus Drugs (Cytotoxic and Immunosuppressive Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Systemic Lupus Erythematosus Drugs (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Systemic Lupus Erythematosus Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Systemic Lupus Erythematosus Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Systemic Lupus Erythematosus Drugs (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Systemic Lupus Erythematosus Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Systemic Lupus Erythematosus Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: North America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: North America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: United States: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: United States: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Canada: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Canada: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Asia-Pacific: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: China: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: China: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Japan: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Japan: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: India: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: India: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: South Korea: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: South Korea: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Australia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Australia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Indonesia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Indonesia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Europe: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Europe: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Germany: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Germany: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: France: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: France: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: United Kingdom: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: United Kingdom: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Italy: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Italy: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Spain: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Spain: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Russia: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Russia: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Latin America: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Latin America: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Brazil: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Brazil: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Mexico: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Mexico: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market: Breakup by Country (in %), 2024
Figure 71: Middle East and Africa: Systemic Lupus Erythematosus Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Global: Systemic Lupus Erythematosus Drugs Industry: Drivers, Restraints, and Opportunities
Figure 73: Global: Systemic Lupus Erythematosus Drugs Industry: Value Chain Analysis
Figure 74: Global: Systemic Lupus Erythematosus Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Systemic Lupus Erythematosus Drugs Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Mode of Delivery (in Million USD), 2025-2033
Table 4: Global: Systemic Lupus Erythematosus Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Systemic Lupus Erythematosus Drugs Market: Competitive Structure
Table 6: Global: Systemic Lupus Erythematosus Drugs Market: Key Players

Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials